Amid apprehension in some international markets over the recent export restrictions imposed by India on a basket of active pharmaceutical ingredients (APIs) and formulations, there appears to be ongoing dialog between industry and the government to strike a balance to safeguard both domestic medicines security and commercial opportunities.
On 3 March, India notified a list of 26 APIs and formulations, including paracetamol, tinidazole and metronidazole, for which exports...